Trending...
- Tacoma: Applicants Sought for the Human Services Commission
- Sylvester Anthony III Introduces His Artist Journey with Debut Single "Cherish"
- Ricci's Painting & Contracting Expands Home Transformation Services
SEATTLE ~ Seattle, WA - Tasso, Inc., a leading provider of patient-centric blood collection solutions, has announced the launch of their new service, Tasso Care® for Prescreening. This end-to-end solution aims to improve the success of prescreening programs by expanding on the company's expertise in remote blood collection and analysis.
Tasso Care for Prescreening is specifically designed to support the prescreening of participants in clinical trials for various cardiometabolic and serostatus markers. The company plans to add additional panels for immunology, cardiovascular disease, and other therapeutic areas throughout the first quarter of 2024 as validation protocols are completed.
According to Tasso CEO and Co-Founder Ben Casavant, PhD, screening participants is a major bottleneck in drug development that often leads to trial delays and high screen failure rates. With Tasso Care, this process is revolutionized by replacing time-consuming clinic visits with convenient and automated prescreening testing at scale.
More on Washingtoner
By offering a virtually painless blood draw experience from the comfort of home, Tasso aims to increase clinical trial engagement rates by simplifying the operational process and optimizing the participants' experience. This also ensures a high-quality sample is returned to the lab. Additionally, Tasso Care allows for large populations to be screened simultaneously anytime and anywhere, ultimately increasing trial access and diversity.
Casavant believes that accelerating and expanding access to clinical trials is crucial in improving healthcare. He states that trials often face enrollment delays due to difficulties in identifying rare populations and obtaining up-to-date data. With Tasso Care for Prescreening, these challenges can be overcome as screening becomes more scalable and convenient.
It should be noted that Tasso Care for Prescreening is intended for use under institutional review board (IRB)-reviewed prescreening protocols. To learn more about this new service from Tasso Inc., please visit their website at www.tassoinc.com/prescreening.
Tasso Care for Prescreening is specifically designed to support the prescreening of participants in clinical trials for various cardiometabolic and serostatus markers. The company plans to add additional panels for immunology, cardiovascular disease, and other therapeutic areas throughout the first quarter of 2024 as validation protocols are completed.
According to Tasso CEO and Co-Founder Ben Casavant, PhD, screening participants is a major bottleneck in drug development that often leads to trial delays and high screen failure rates. With Tasso Care, this process is revolutionized by replacing time-consuming clinic visits with convenient and automated prescreening testing at scale.
More on Washingtoner
- City of Tacoma Observes Independence Day
- Make America French Again Launches National Campaign
- AI Researcher Releases Punk Album "You Can't Kill The Signal" In Response To Mythos and Fable Ban
- RAS AP Consulting Expands AP Governance & Automation Practice and Named Finalist for Heidelberg Materials SAP Vendor & Customer Data Project
- Spokane: Domestic Disturbance Call Results in Serious Injury to Dog
By offering a virtually painless blood draw experience from the comfort of home, Tasso aims to increase clinical trial engagement rates by simplifying the operational process and optimizing the participants' experience. This also ensures a high-quality sample is returned to the lab. Additionally, Tasso Care allows for large populations to be screened simultaneously anytime and anywhere, ultimately increasing trial access and diversity.
Casavant believes that accelerating and expanding access to clinical trials is crucial in improving healthcare. He states that trials often face enrollment delays due to difficulties in identifying rare populations and obtaining up-to-date data. With Tasso Care for Prescreening, these challenges can be overcome as screening becomes more scalable and convenient.
It should be noted that Tasso Care for Prescreening is intended for use under institutional review board (IRB)-reviewed prescreening protocols. To learn more about this new service from Tasso Inc., please visit their website at www.tassoinc.com/prescreening.
0 Comments
Latest on Washingtoner
- Vierra Communities Adds Operations of Two Skilled Nursing Facilities in the DC Metro Area
- Slotozilla Introduces a Centralized Resource for World Cup Bonus Offers
- Webinar Announcement: Built for Trust: Latitude's 0 to 1 Compliance Playbook for Modern Cross-Border Payments
- OneVizion Names AI Leader Matthew Kirk as Chief Operating Officer to Drive Governed AI Across Telecom and Electric Utilities
- Dentists launch independent platform to help practices choose the right technology
- Contracting Resources Group Recognized by The Daily Record as a 2026 In the Lead: Best Women-Owned Businesses Honoree
- Woodforest Acceptance Solutions and AlpacaBOSS Launch Partnership
- Spokane: SPD is Investigating a Shooting that Occurred Early Monday
- Tacoma Residents Report Improved Satisfaction in 68 of 80 City Service Areas in 2026 Community Survey
- New "Lakeside Picnic Ride" Package in Japan's Lake Chuzenji region of Nikko: July 1- November 30, 2026
- 80 Arts, Culture, Heritage, and Science Organizations Funded by Tacoma Creates for 2026-2027
- Deputy Mayor Joe Bushnell Presents Tacoma Minimum Wage Community and Stakeholder Engagement Report to Economic Development Committee
- Spokane: America's 250th Celebrated in Riverfront Park with Incredible Lineup
- Spokane: City Details Fourth of July Activities, Closures
- Former MP Shri GV Harsha Kumar Meets AICC President Mallikarjun Kharge
- Tacoma: System Development Charges for Wastewater and Stormwater Utilities to Take Effect on July 1
- Two Attorneys at The Stanley Law Group Named to 2026 South Carolina Super Lawyers List
- IGH Naturals Announces Peer-Reviewed HuMOLYTE® Study Published in Frontiers in Nutrition
- Allstream Energy Partners Expands AI-Optimized Website Development Division to Meet Growing Demand in GEO / AEO Services
- America's Workforce Solution Named an OpenAI SMB Channel Partner, Bringing Enterprise-Grade AI to Main Street